Back to User profile » Ms Isha Mol
Papers published by Ms Isha Mol:
Short Report
Matching-Adjusted Indirect Comparison of Elranatamab versus Teclistamab in Patients with Triple-Class Exposed/Refractory Multiple Myeloma: Updated Results
Mol I, Hu Y, LeBlanc TW, Cappelleri JC, Chu H, Nador G, Aydin D, Perez Cruz I, Hlavacek P
Journal of Blood Medicine 2025, 16:233-239
Published Date: 14 May 2025
Original Research
Economic Impact of Elranatamab for Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Shah B, Sandin R, Liu Y, Bobolts LR, Hu Y, Mol I, Schepart A, Hughes DM, Hart J, Hlavacek P
ClinicoEconomics and Outcomes Research 2025, 17:289-302
Published Date: 8 April 2025